Rachel Erlich

Observer
DISC Type : ci

Vice President, Translational Medicine & Integrated Research at Blueprint Medicines

Cambridge, Massachusetts, United States

Overview

Rachel Erlich is the Vice President of Translational Medicine & Integrated Research at Blueprint Medicines. With a PhD in Biology from MIT, she has extensive experience in oncology and biomedical informatics, notably spending a decade at Foundation Medicine where she rose from Director to Vice President.

After a decade of progressive leadership at Foundation Medicine, she moved into a new senior role, highlighting a significant and impactful career trajectory within a single organization.

Personality Overview

Assertive

Curious

Value Driven

They can sound friendly and charming but can quickly change gears to become inquisitive and probing.  They are generally good communicators and can be hard to convince. They often ask many questions and rely heavily on information and documentation.

Topics They Care About

Translational Medicine
Her career is focused on bridging the gap between preclinical research and clinical application, reflected in her senior leadership roles at Blueprint Medicines and Foundation Medicine.
Oncology Genomics
Co-authored numerous publications on the comprehensive genomic profiling of various cancers, including gastric carcinoma and pediatric gliomas, to find new routes for targeted therapies.
Team & Culture
Publicly expresses deep gratitude for her colleagues' contributions and actively supports former team members during career transitions, showing she values her team.

Media Appearances

Rachel has no verified media appearances

Work History

7-2022
Vice President, Translational Medicine & Integrated Research at Blueprint Medicines
6-2019 - 7-2022
Vice President, Translational Oncology & Clinical Reporting (formerly Biomedical Informatics) at Foundation Medicine
10-2015 - 6-2019
Senior Director, Biomedical Informatics (Translational Oncology) at Foundation Medicine
10-2012 - 10-2015
Director, Biomedical Informatics at Foundation Medicine
2-2012 - 10-2012
Group Leader - Center for Cancer Genome Discovery (Non-tenure track faculty) at Dana-Farber Cancer Institute

Education

2002 - 2007
PhD from Massachusetts Institute of Technology
B.S. from Cornell University

More Information

Social Presence :

Prographics :

Exp : 22 Location : Cambridge, Massachusetts, United States Job Level : Senior Designation : Vice President, Translational Medicine & Integrated Research at Blueprint Medicines
URL has been copied!

Insights For Selling To Rachel

During A Call Or A Meeting

DO's

  • Share testimonials from known people and give multiple examples of product value
  • Use phrases like ‘clear proof that’, ‘data shows’ etc.
  • Ask them questions to understand their needs better while staying affable

DONT's

  • Don’t rely excessively on your relationship with them to win the deal
  • Don’t be too objective but make sure to pad your storytelling with data points
  • Avoid making offhand commitments

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Rachel is

  • Clear proof of product value matters to them, followed by others' testimonials and rapport.
  • Will you ever get a clear answer from Rachel

  • They are practical and friendly, don't expect a clear-cut response often.

Insights For Deal Planning

    How fast (or slow) will Rachel move?

  • They like to perform full analysis and can take time to make any decision.
  • Can Rachel take some risk or not?

  • They systematically evaluate all decisions and are unlikely to take many risks.

You And Rachel

Personality Compatibility


Other Blueprint Medicines Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.